Frontlight ResearchEarly access
Active, not recruitingNo phase
Qualitative Assessment of the Impact of TTNS on QOL and Participation
Key facts
- Who runs it
- Medstar Health Research Institute
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 75 people enrolled
- Started
- 31 May 2022
- Ended
- Sept 2026
- Type of study
- Observational
- Treatments tested
- Semi-structured interview
- Record updated
- 11 September 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Other criteria
- Inclusion:
- Participated in TTNS Study for 1 year
Where in United States
- MedStar National Rehabilitation HospitalWashington D.C., United States
About the trial
What the trial wants to find out
This study through the use of semi-structured interviews or focus groups will explore the lived experience with Transcutaneous Tibial Nerve Stimulation (TTNS) with Neurogenic Lower Urinary Tract Dysfunction to generate user-defined themes regarding bladder function and catheter-related barriers and the daily impacts on one's life.
The group in the trial
- Subjects who used TTNS
Subjects will have Neurogenic Lower Urinary Tract Dysfunction and will have participated in a study with TTNS. n=20
Treatment: Semi-structured interview
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Qualitative Assessment of the Impact of Transcutaneous Tibial Nerve Stimulation (TTNS) on Quality of Life and Participation
- Record updated
- 11 September 2026